Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study.
Hou L, Wang T, Chen D, She Y, Deng J, Yang M, Zhang Y, Zhao M, Zhong Y, Ma M, Zhao G, Chen Y, Xie D, Zhu Y, Chen Q, Wu C, Chen C; Multi-omics Classifier for Pulmonary Nodules (MISSION) Collaborative Group. Hou L, et al. Mod Pathol. 2022 Jun;35(6):749-756. doi: 10.1038/s41379-021-00994-5. Epub 2022 Jan 10. Mod Pathol. 2022. PMID: 35013526 Free article.
Implementation of artificial intelligence in the histological assessment of pulmonary subsolid nodules.
Deng J, Zhao M, Li Q, Zhang Y, Ma M, Li C, Wang J, She Y, Jiang Y, Zhang Y, Wang T, Wu C, Hou L, Zhong S, Jin S, Qian D, Xie D, Zhu Y, Tandon YK, Snoeckx A, Jin F, Yu B, Zhao G, Chen C. Deng J, et al. Among authors: yu b. Transl Lung Cancer Res. 2021 Dec;10(12):4574-4586. doi: 10.21037/tlcr-21-971. Transl Lung Cancer Res. 2021. PMID: 35070762 Free PMC article.
PET/CT-based deep learning grading signature to optimize surgical decisions for clinical stage I invasive lung adenocarcinoma and biologic basis under its prediction: a multicenter study.
Zhong Y, Cai C, Chen T, Gui H, Chen C, Deng J, Yang M, Yu B, Song Y, Wang T, Chen Y, Shi H, Xie D, Chen C, She Y. Zhong Y, et al. Among authors: yu b. Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):521-534. doi: 10.1007/s00259-023-06434-7. Epub 2023 Sep 19. Eur J Nucl Med Mol Imaging. 2024. PMID: 37725128
Integrated multiomics signatures to optimize the accurate diagnosis of lung cancer.
Zhao M, Xue G, He B, Deng J, Wang T, Zhong Y, Li S, Wang Y, He Y, Chen T, Zhang J, Yan Z, Hu X, Guo L, Qu W, Song Y, Yang M, Zhao G, Yu B, Ma M, Liu L, Sun X, She Y, Xie D, Zhao D, Chen C. Zhao M, et al. Among authors: yu b. Nat Commun. 2025 Jan 2;16(1):84. doi: 10.1038/s41467-024-55594-z. Nat Commun. 2025. PMID: 39747216 Free PMC article.
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial.
Yue D, Wang W, Liu H, Chen Q, Chen C, Liu L, Zhang P, Zhao G, Yang F, Han G, Cheng Y, Yu B, Yang Y, Chen H, Jiang J, Tan L, Xu S, Mao N, Hu J, Zhang L, Yao B, Wang S, Wang RH, Zheng W, Wang C; RATIONALE-315 investigators. Yue D, et al. Among authors: yu b. Lancet Respir Med. 2024 Nov 21:S2213-2600(24)00269-8. doi: 10.1016/S2213-2600(24)00269-8. Online ahead of print. Lancet Respir Med. 2024. PMID: 39581197
12,493 results
You have reached the last available page of results. Please see the User Guide for more information.